Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis

Authors
Publication date
Publisher
'Ferrata Storti Foundation (Haematologica)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.3324%2Fhaematol.20...
      Last time updated on 01/04/2019